115 related articles for article (PubMed ID: 15081580)
1. Differential inhibition by alpha and epsilonPKC pseudosubstrate sequences: a putative mechanism for preferential PKC activation in neonatal cardiac myocytes.
Johnson JA
Life Sci; 2004 May; 74(25):3153-72. PubMed ID: 15081580
[TBL] [Abstract][Full Text] [Related]
2. Epsilon protein kinase C lengthens the quiescent period between spontaneous contractions in rat ventricular cardiac myocytes and trabecula.
Ogbi M; Wingard CJ; Ogbi S; Johnson JA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):251-61. PubMed ID: 15452687
[TBL] [Abstract][Full Text] [Related]
3. Cell-specific role for epsilon- and betaI-protein kinase C isozymes in protecting cortical neurons and astrocytes from ischemia-like injury.
Wang J; Bright R; Mochly-Rosen D; Giffard RG
Neuropharmacology; 2004 Jul; 47(1):136-45. PubMed ID: 15165841
[TBL] [Abstract][Full Text] [Related]
4. Lithium treatment inhibits protein kinase C translocation in rat brain cortex.
Wang HY; Johnson GP; Friedman E
Psychopharmacology (Berl); 2001 Oct; 158(1):80-6. PubMed ID: 11685387
[TBL] [Abstract][Full Text] [Related]
5. An epsilonPKC-selective inhibitor attenuates back phosphorylation of a low molecular weight protein in cardiac myocytes.
Johnson JA
Cell Signal; 2003 Jan; 15(1):123-30. PubMed ID: 12401527
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c oxidase subunit IV as a marker of protein kinase Cepsilon function in neonatal cardiac myocytes: implications for cytochrome c oxidase activity.
Ogbi M; Chew CS; Pohl J; Stuchlik O; Ogbi S; Johnson JA
Biochem J; 2004 Sep; 382(Pt 3):923-32. PubMed ID: 15339253
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C isoform activation and endothelin-1 mediated defects in myocyte contractility after cardioplegic arrest and reperfusion.
Mukherjee R; Apple KA; Squires CE; Kaplan BS; McLean JE; Saunders SM; Stroud RE; Spinale FG
Circulation; 2006 Jul; 114(1 Suppl):I308-13. PubMed ID: 16820591
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C epsilon and gamma: involvement in formalin-induced nociception in neonatal rats.
Sweitzer SM; Wong SM; Peters MC; Mochly-Rosen D; Yeomans DC; Kendig JJ
J Pharmacol Exp Ther; 2004 May; 309(2):616-25. PubMed ID: 14762097
[TBL] [Abstract][Full Text] [Related]
9. Effect of alpha-protein kinase C neutralizing antibodies and the pseudosubstrate peptide on phosphorylation, migration, and growth of REF52 cells.
Liao L; Jaken S
Cell Growth Differ; 1993 Apr; 4(4):309-16. PubMed ID: 8494793
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the spontaneous rate of contraction of neonatal cardiac myocytes by protein kinase C isozymes. A putative role for the epsilon isozyme.
Johnson JA; Mochly-Rosen D
Circ Res; 1995 Apr; 76(4):654-63. PubMed ID: 7895339
[TBL] [Abstract][Full Text] [Related]
11. Isozyme-specific inhibitors of protein kinase C translocation: effects on contractility of single permeabilized vascular muscle cells of the ferret.
Lee YH; Kim I; Laporte R; Walsh MP; Morgan KG
J Physiol; 1999 Jun; 517 ( Pt 3)(Pt 3):709-20. PubMed ID: 10358112
[TBL] [Abstract][Full Text] [Related]
12. Protease-activated receptor-2 stimulates intestinal epithelial chloride transport through activation of PLC and selective PKC isoforms.
van der Merwe JQ; Moreau F; MacNaughton WK
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1258-66. PubMed ID: 19359428
[TBL] [Abstract][Full Text] [Related]
13. Amyloid beta peptide directly inhibits PKC activation.
Lee W; Boo JH; Jung MW; Park SD; Kim YH; Kim SU; Mook-Jung I
Mol Cell Neurosci; 2004 Jun; 26(2):222-31. PubMed ID: 15207847
[TBL] [Abstract][Full Text] [Related]
14. PKC mediates cyclic stretch-induced cardiac hypertrophy through Rho family GTPases and mitogen-activated protein kinases in cardiomyocytes.
Pan J; Singh US; Takahashi T; Oka Y; Palm-Leis A; Herbelin BS; Baker KM
J Cell Physiol; 2005 Feb; 202(2):536-53. PubMed ID: 15316932
[TBL] [Abstract][Full Text] [Related]
15. [The effect of chelerythrine on the hypertrophy of cardiac myocytes of neonatal rats induced by different glucose levels and its mechanism].
Zhang WB; Wang M; Zhou BQ; Zhu JH; Fu GS
Yao Xue Xue Bao; 2009 Feb; 44(2):115-20. PubMed ID: 19408678
[TBL] [Abstract][Full Text] [Related]
16. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.
Chen L; Hahn H; Wu G; Chen CH; Liron T; Schechtman D; Cavallaro G; Banci L; Guo Y; Bolli R; Dorn GW; Mochly-Rosen D
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11114-9. PubMed ID: 11553773
[TBL] [Abstract][Full Text] [Related]
17. Protection from the effects of metabolic inhibition and reperfusion in contracting isolated ventricular myocytes via protein kinase C activation.
Hudman D; Standen NB
J Mol Cell Cardiol; 2004 Aug; 37(2):579-91. PubMed ID: 15276027
[TBL] [Abstract][Full Text] [Related]
18. Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts.
Tanaka M; Terry RD; Mokhtari GK; Inagaki K; Koyanagi T; Kofidis T; Mochly-Rosen D; Robbins RC
Circulation; 2004 Sep; 110(11 Suppl 1):II194-9. PubMed ID: 15364862
[TBL] [Abstract][Full Text] [Related]
19. Altered PKC expression and phosphorylation in response to the nature, direction, and magnitude of mechanical stretch.
Bullard TA; Hastings JL; Davis JM; Borg TK; Price RL
Can J Physiol Pharmacol; 2007 Feb; 85(2):243-50. PubMed ID: 17487266
[TBL] [Abstract][Full Text] [Related]
20. Norepinephrine-induced changes in gene expression of phospholipase C in cardiomyocytes.
Singal T; Dhalla NS; Tappia PS
J Mol Cell Cardiol; 2006 Jul; 41(1):126-37. PubMed ID: 16714034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
